Trichloroethylene cancer risk: Simplified calculation of PBPK-Based MCLs for cytotoxic end points

Regulatory Toxicology and Pharmacology

Volumn 25, Issue 1, 1997, Pages 26-42

  Bogen, Kenneth T ^a   Gold, Lois Swirsky ^b  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ARTICLE; CALCULATION; CANCER RISK; CARCINOGENICITY; CYTOTOXICITY; DOSE RESPONSE; HAMSTER; HUMAN; KIDNEY CANCER; LIVER CANCER; MAXIMUM ALLOWABLE CONCENTRATION; MODEL; MOUSE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RAT; RISK ASSESSMENT;

ANIMALIA; CRICETINAE; RODENTIA;

EID: 0031080141     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1996.1070     Document Type: Article

References (121)

1. Abelson, P. H. (1993). Health risk assessment. Regul. Toxicol. Pharmacol. 17, 219-223.
2. Aitchison, J., and Brown, J. A. C. (1957). The Lognormal Distribution. Cambridge Univ. Press, London.
3. Allen, B. C., and Fisher, J. W. (1993). Pharmacokinetic modeling of trichloroethlyene and trichloroacetic acid in humans. Risk Anal. 15, 71-86.
4. Ames, B., and Gold, L. S. (1990). Too many rodent carcinogens Proc. Natl. Acad. Sci. USA 87, 7772-7776.
5. American Council of Governmental Industrial Hygienists (ACGIH) (1993). Threshold Limit Values (TLVs). ACGIH, Cincinnatti.
6. Andelman, J. B. (1990). Total exposure to volatile organic compounds in potable water. In Significance and Treatment of Volatile Organic Compounds in Water Supplies (N. M. Ram, R. F. Christman, and K. P. Cantor, Eds.), pp. 485-504. Lewis, Chelsea, MI.
7. Anttila, A., Pukkala, E., Sallmén, M., Hernberg, S., and Hemminki, K. (1995). Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J. Occup. Environ. Med. 37, 797-806.
8. Armitage, P., and Doll, R. (1957). A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer 11, 161-169.
9. Axelson, O., Selden, A., Andersson, K., and Hogstedt, C. (1994). Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J. Occup. Med. 36, 556-562.
10. Bell, Z. G., Olsen, K. J., and Benya, T. J. (1978). Final Report of Audit Findings of the Manufacturing Chemists Association (MCA): Administered Trichloroethylene (TCE) Chronic Inhalation Study at Industrial Bio-Test Laboratories, Inc., Decator, Illinois. Unpublished study reported in EPA (1985).
11. Birner, G., Vamvakas, S., Dekant, W., and Henschler, D. (1993). Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethylene exposure in humans: Implications for the risk of trichloroethylene exposure. Environ. Health Perspect. 99, 281-284.
12. Bogen, K. T. (1988). Pharmacokinetics for regulatory risk assessment: The case of trichloroethlyene. Regul. Toxicol. Pharmacol. 8, 447-466.
13. Bogen, K. T. (1989). Cell proliferation kinetics and multistage cancer risk models. J. Natl. Cancer Inst. 81, 267-277.
14. Bogen, K. T. (1990). Risk extrapolation for chlorinated methanes as promoters vs initiators of multistage carcinogenesis. Fundam. Appl. Toxicol. 15, 536-557.
15. Bogen, K. T., and Hall, L. C. (1989). Pharmacokinetics for regulatory risk assessment: The case of 1,1,1-trichloroethane (methyl chloroform). Regul. Toxicol. Pharmacol. 10, 26-50.
16. Bogen, K. T., and McKone, T. E. (1988). Linking indoor air and pharmacokinetic models to assess tetrachloroethylene risk. Risk Anal. 8, 509-520.
17. Bogen, K. T., Hall, L. C., McKone, T. E., Layton, D. W., and Patton, S. E. (1988). Health Risk Assessment of Trichloroethylene in California Drinking Water. Report prepared for the California Public Health Foundation and California Department of Health Services. Lawrence Livermore National Laboratory, Livermore, CA.
18. Brown, L. P., Farrar, D. G., and DeRooij, C. G. (1990). Health risk assessment of environmental exposure to trichloroethylene. Regul. Toxicol. Pharmacol. 11, 24-41.
19. Bruckner, J. V., Davis, B. D., and Blancato, J. N. (1989). Metabolism, toxicity, and carcinogenicity of trichloroethylene. Crit. Rev. Toxicol. 20, 31-50.
20. Buben, J. A., and O'Flaherty, E. J. (1985). Delineation of the role of metabolism in the hepatoxicity of trichloroethylene and perchloroethylene: A dose-effect study. Toxicol. Appl. Pharmacol. 78, 105-122.
21. Bull, J. F., Sanchez, I. M., Nelson, M. A., Larson, J. L., and Lansing, A. J. (1990). Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63, 341-359.
22. California. (1994). California Code of Regulations, Title 22, Chapter 15 (Domestic Water Quality and Monitoring), Article 5.5 (Primary Standards - Organic Chemicals), Section 6444 (as amended September 12, 1994).
23. Clewell, H. J., Gentry, P. R., Gearhart, J. M., Allen, B. C., and Andersen, M. E. (1995). Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: Examples with vinyl chloride and trichloroethylene. Chemosphere 31, 2561-2578.
24. Cohen, S. M., and Ellwein, L. B. (1990). Cell proliferation in carcinogenesis. Science 249, 1007-1011.
25. Cohen, S. M., and Ellwein, L. B. (1991). Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51, 6493-6505.
26. Cohn, P., Klotz, J., Bove, F., Berkowitz, M., and Fagliano, J. (1994). Drinking water contamination and the incidence of leukemia and non-Hodgkin's lymphoma. Environ. Health Perspect. 102, 556-561.
27. Commandeur, J. N. M., and Vermeulen, N. P. E. (1990). Identification of N-acetyl-(2,2-dichlorovinyl) and N-acetyl-(1,2-dichlorovinyl)-L-cysteine as two regioisomeric mercapturic acids of trichloroethylene in the rat. Chem. Res. Toxicol. 3, 212-218.
28. Commandeur, J. N. M., Boogaard, P. J., Mulder, G. J., and Vermeulen, N. P. E. (1991). Mutagenicity and cytotoxicity of two regioisomeric mercapturic acids and cystein S-conjugates of trichloroethylene. Arch. Toxicol. 65, 373-380.
29. Daniel, F. B., DeAngelo, A. B., Stober, J. A., Olsen, G. R., and Page, N. P. (1992). Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 19, 159-168.
30. Davidson, I. W. F., and Beliles, R. P. (1991). Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab. Rev. 23, 493-599.
31. DeAngelo, A. B., and Daniel, F. B. (1990). The comparative carcinogenicity of dichloroacetic acid (DCA) and trichloroacetic acid (TCA) in the male B3C3F1 mouse. Toxicologist 10, 148. [Abstract]
32. DeAngelo, A. B., Daniel, F. B., Stober, J. A., and Olsen, G. R. (1991). The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 16, 337-347.
33. Dees, C., and Travis, C. (1993). The mitogenic potential of trichloroethylene in B6C3F1 mice. Toxicol. Lett. 69, 129-137.
34. Dees, C., and Travis, C. (1994). Trichloroacetate stimulation of liver DNA synthesis in male and female mice. Toxicol. Lett. 70, 343-355.
35. Dekant, W., Metzler, M., and Henschler, D. (1984). Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans. Biochem. Pharmacol. 33, 2021-2027.
36. Dekant, W., Metzler, M., and Henschler, D. (1986a). Identification of S-1,2-dichlorovinyl-N-acetyl cysteine as a urinary metabolite of trichloroethylene: A possible explanation for its nephrotoxicity in male rats. Biochem. Pharmacol. 35, 2455-2458.
37. Dekant, W., Schultz, A., Metzler, M., and Henschler, D. (1986b). Absorption, elimination and metabolism of trichloroethylene: A quantitative comparison between rats and mice. Xenobiotica 16, 143-152.
38. Dekant, W., Vamvakas, S., and Anders, M. W. (1989). Bioactivation of nephrotoxic halokenes by glutathione conjugation: Formation of toxic and mutagenic intermediates by cysteine conjugate β-lyase. Drug Metab. Rev. 20, 43-83.
39. Dekant, W., Vamvakas, S., Berthold, K., Schmidt, S., Wild, D., and Henschler, D. (1986c). Bacterial β-lyase cleavage and mutagenicity of cysteine conjugate derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene, and hexachlorobutadiene. Chem. Biol. Interact. 60, 31-45.
40. Dekant, W., Vamvakas, S., Berthold, K., Schmidt, S., Wild, D., and Henschler, D. (1990). Metabolism of trichloroethylene in vivo and in vitro: Evidence for activation by glutathione conjugation. Chem. Biol. Interact. 73, 89-101.
41. Dourson, M. L., and Stara, J. F. (1983). Regulatory history and experimental support of uncertainty (safety) factors. Regul. Toxicol. Pharmacol. 3, 224-238.
42. 1 mice. Chronobiol. Int. 7, 291-303.
43. 3F1 mice: Changes in the circadian rhythms of physiological and behavioral variables. In Biological Effects of Dietary Restriction (L. Fishbein, Ed.), pp. 245-263. Springer-Verlag, New York.
44. Eacho, P. I., Foxworthy, P. S., Johnson, W. D., Hoover, D. M., and White, S. L. (1986). Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophone in rats and comparison with other species. Toxicol. Appl. Pharmacol. 83, 430-437.
45. Elcombe, C. R. (1985). Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: A biochemical human hazard assessment. Arch. Toxicol. 8(Suppl.), 6-17.
46. Elcombe, C. R., Rose, M. S., and Pratt, I. S. (1985). Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: Possible relevance to species differences in hepatocarcinogenicity. Toxicol. Appl. Pharmacol. 79, 365-376.
47. Elfarra, A. A., and Anders, M. W. (1984). Renal processing of glutathione conjugates: Role in nephrotoxicity. Biochem. Pharmacol. 33, 3729-3732.
48. Elfarra, A. A., Jakobson, I., and Anders, M. W. (1986a). Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. Biochem. Pharmacol. 35, 282-288.
49. Elfarra, A. A., Lash, L. H., and Anders, M. W. (1986b). Metabolic activation and detoxication of nephrotoxic cysteine and homocystein S-conjugates. Proc. Natl. Acad. Sci. USA 83, 2667-2671.
50. Fagliano, J., Berry, M., Bove, F., and Burke, T. (1990). Drinking water contamination and the incidence of leukemia: An ecologic study. Am. J. Public Health 80, 1209-1212.
51. Fahrig, R., Madle, S., and Baumann, H. (1995). Genetic toxicology of trichloroethylene. Mutat. Res. 340, 1-36.
52. Fan, A. (1988). Trichloroethylene: Water contamination and health risk assessment. Rev. Environ. Contam. Toxicol. 101, 55-92.
53. Ferreira-Gonzales, A., DeAngelo, A. B., Nasim, S., and Garrett, C. T. (1995). Ras oncogene activation during hepatocarcinogenesis in B6C3F1 male mice by dichloroacetic acid and trichloroacetic acids. Carcinogenesis 16, 494-500.
54. Fisher, J. W., and Allen, B. C. (1993). Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models. Risk Anal. 15, 87-95.
55. Fisher, J. W., Gargas, M. L., Allen, B. C., and Andersen, M. E. (1991). Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. Toxicol. Appl. Pharmacol. 109, 183-195.
56. Fisher, R. A. (1973). Statistical Methods for Research Workers, pp. 98-101. Hafner, New York.
57. Fukuda, K., Takemoto, K., and Tsuruta, H. (1983). Inhalation carcinogenicity of trichloroethylene in mice and rats. Ind. Health 21, 243-254.
58. Goeptar, A. R., Commandeur, J. N. M., vanOmmen, B., vanBladeren, P. J., and Vermeulen, N. P. E. (1995). Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity: Relevance of the mercapturic acid pathway. Chem. Res. Toxicol. 8, 3-21.
59. Gold, L. S., Garfinkel, G. B., and Slone, T. H. (1994). Setting priorities among possible carcinogenic hazards in the workplace. In Chemical Risk Assessment and Occupational Health (M. Smith, D. C. Christiani, and K. T. Helsey, Eds.), pp. 91-103. Auburn House, Westport, CT.
60. Gold, L. S., Slone, T. H., Manley, N. B., Garfinkel, G. B., Rohrbach, L., and Ames, B. N. (1997). Carcinogenic potency database. In Handbook of Carcinogenic Potency and Genotoxicity Databases (L. S. Gold and E. Zeiger, Eds.), pp. 1-605. CRC Press, Boca Raton, FL.
61. Goldsworthy, T. L., Lyght, O., Burnett, V., and Popp, J. A. (1988). Potential role of α-2μ-globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethylene. Toxicol. Appl. Pharmacol. 96, 367-379.
62. Green, T. (1990). Species differences in carcinogenicity: The role of metabolism in human risk evaluation. Teratogen. Carcinogen. Mutagen. 10, 103-113.
63. Green, T., and Prout, M. S. (1985). Species differences in response to trichloroethylene. Toxicol. Appl. Pharmacol. 79, 401-411.
64. Hathway, D. E. (1980). Consideration of the evidence for mechanisms of 1,1,2-trichloroethylene metabolism, including new identification of its dichloroacetic acid and trichloroacetic acid metabolites in mice. Cancer Lett. 8, 263-269.
65. Henschler, D., Varnvakas, S., Lammert, M., Dekant, W., Kraus, B., Thomas, B., and Ulm, K. (1995). Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethylene. Arch. Toxicol. 69, 291-299.
66. Henschler, D. H., Romen, W., and Eder, E. (1984). Carcinogenicity study of trichloroethylene, with and without epoxide stabilizers in mice. J. Cancer Res. Clin. Oncol. 107, 149-156.
67. Henschler, D. H., Romen, W., Elasser, H. N., Reichert, D., Eder, E., and Radwan, Z. (1980). Carcinogenicity study of trichloroethylene by longterm inhalation in three animal species. Arch. Toxicol. 43, 237-248.
68. Herren-Freund, S. L., Pereira, M. A., Khoury, M. D., and Olson, G. (1987). The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol. Appl. Pharmacol. 90, 183-189.
69. International Agency for Research on Cancer (IARC) (1982). Monographs on Evaluation of the Carcinogenic Risk to Humans, pp. 247-249. IARC, Geneva.
70. International Agency for Research on Cancer (IARC) (1988). Monographs on Evaluation of the Carcinogenic Risk to Humans, pp. 364-365. IARC, Geneva.
71. International Agency for Research on Cancer (IARC) (1995). Monographs on Evaluation of the Carcinogenic Risk to Humans, Vol. 63, Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals, pp. 75-137. IARC, Lyon, France.
72. Jorgenson, T. A., Meierhenry, E. F., Rushbrook, C. J., Bull, R. J., and Robinson, M. (1985). Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 5, 760-769.
73. Kjellstrand, P., Holmquist, B., Mandahl, N., Edstrom, A., and Bjerkemo, M. (1983a). Effects of continuous trichloroethylene inhalation on different strains of mice. Acta Pharmacol. Toxicol. 53, 375-384.
74. Kjellstrand, P., Holmquist, B., Mandahl, N., Edstrom, A., and Bjerkemo, M. (1983b). Trichloroethylene: Further studies of effects on body and organ weights and plasma butylcholinesterase activity in mice. Acta Pharmacol. Toxicol. 53, 369-374.
75. Kjellstrand, P. A., Edstrom, A., Bjerkemo, M., and Holmquist, B. (1982). Effects of trichloroethylene inhalation on acid phosphates in rodent brain. Toxicol. Lett. 10, 1-5.
76. Koivusalo, M., Jaakkola, J. J. K., Vartiainen, T., Hakulinen, T., Karjalainen, S., Pukkala, E., and Tuomisto, J. (1994). Drinking water mutagenicity and gastrointestinal and urinary tract cancers: An ecological study in Finland. Am. J. Public Health 84, 1223-1228.
77. Larson, J. L., and Bull, R. J. (1992a). Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol. Appl. Pharmacol. 115, 268-277.
78. Larson, J. L., and Bull, R. J. (1992b). Species differences in the metabolism of trichoroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol. Appl. Pharmacol. 115, 278-285.
79. Larson, J. L., Wolf, D. C., and Butterworth, B. E. (1994). Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: Comparison of administration by gavage in corn oil vs. ad libitum in drinking water. Fundam. Appl. Toxicol. 22, 90-102.
80. Lipsky, M. M. (1994). Mechanistic Basis and Relevance of Kidney Tumors in Male Rats for Use in Risk Assessment. American Water Works Association Research Foundation, Denver, CO.
81. Mallin, K. (1990). Investigation of a bladder cancer cluster in northwestern Illinois. Am. J. Epidemiol. 132(1 Suppl), S96-S106.
82. Maltoni, C., Lefemine, G., and Cotti, G. (1986). Archives of Research on Industrial Carcinogenesis, Vol. V, Experimental Research of Trichloroethylene Carcinogenesis. Princeton Univ. Press, Princeton, NJ.
83. Mather, G. G., Exon, J. H., and Koller, L. D. (1990). Subchronic 90 day toxicity of dichloroacetic and trichloroacetic acid in rats. Toxicology 64, 71-80.
84. McClain, R. M. (1994). Mechanistic considerations in the regulation of classification of chemical carcinogens. In Nutritional Toxicology (F. N. Kotsonis, M. Mackey, and J. Hjelle, Eds.), pp. 273-304. Raven Press, New York.
85. McKone, T. E. (1987). Human exposure to volatile organic compounds in household tap water: The indoor inhalation pathway. Environ. Sci. Technol. 21, 1194-1201.
86. Mirsalis, J. C., Tyson, C. K., Loh, E. N., Steinmetz, K. L., Bakke, J. P., Hamilton, C. M., Spak, D. K., and Spalding, J. W. (1985). Induction of hepatic cell proliferation and unscheduled DNA synthesis in mouse hepatocytes following in vivo treatment. Carcinogenesis 1, 621-625.
87. Mirsalis, J. C., Tyson, C. K., Steinmetz, K. L., Loh, E. N., Hamilton, C. M., Bakke, J. P., and Spalding, J. W. (1989). Measurement of unscheduled DNA synthesis and S-phase synthesis in rodent hepatocytes following in vivo treatment: Testing of 24 compounds. Environ. Mol. Mutagen. 14, 155-164.
88. Monticello, T. M., and Morgan, K. T. (1994). Cell proliferation and formaldehyde-induced respiratory carcinogenesis. Risk Anal. 14, 313-319.
89. Moolgavkar, S. H. (1983). Model for human carcinogenesis: Action of environmental agents. Environ. Health Perspect. 50, 285-291.
90. Moolgavkar, S. H., and Knudson, A. G. (1981). Mutation and cancer: A model for human carcinogenesis. J. Natl. Cancer Inst. 66, 1037-1052.
91. Moolgavkar, S. H., Deweanji, A., and Venzon, D. J. (1988). A stochastic two-stage model for cancer risk assessment: The hazard function and the probability of tumor. Risk Anal. 8, 383-392.
92. Murty, C. V. R., Olson, M. J., Garg, B. D., and Roy, A. K. (1988). Hydrocarbon-induced hyaline droplet nephropathy in male rats during senescence. Toxicol. Appl. Pharmacol. 96, 380-392.
93. National Cancer Institute (NCI) (1976). Carcinogenesis Bioassay of Trichloroethylene, NCI-CG-TR-2, DHEW Publication No. (NIH) 76-802. U.S. Govt. Printing Office, Washington, DC.
94. National Toxicology Program (NTP) (1988). Toxicology and Carcinogenesis Studies of Trichloroethylene (CAS No. 79-01-6) in Four Strains of Rats (ACI, August, Marshall, Osborne-Mendel) (Gavage Studies), NIH Publication No. 88-2529, NTP Technical Rep. Ser. No. 273. National Institutes of Health, NTP, Research Triangle Park, NC.
95. National Toxicology Program (NTP) (1990). Carcinogenesis Studies of Trichloroethylene (Without Epichlorohydrin) (CAS No. 79-01-6) in F344/N Rates and B3C3F1 Mice (Gavage Studies), NIH Publication No. 90-1799. National Institutes of Health, NTP, Research Triangle Park, NC.
96. Pereira, M. A. (1996). Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. Fundam. Appl. Toxicol. 31, 192-199.
97. Pereira, M. A., and Phelps, J. B. (1996). Promotion by dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. Cancer Lett. 102, 133-141.
98. 50: A proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. Environ. Health Perspect. 58, 1-8.
99. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., and Henderson, B. E. (1990). Increased cell division as a cause of human cancer. Cancer Res. 50, 7415-7421.
100. Prout, M. S., Provan, W. M., and Green, T. (1985). Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice. Toxicol. Appl. Pharmacol. 10, 389-400.
101. Rouisse, L., and Chakrabarti, S. K. (1986). Dose-dependent metabolism of trichloroethylene and its relevance to hepatotoxicity in rats. Environ. Res. 40, 450-458.
102. Seldén, A., Hultberg, B., Ulander, A., and Ahlborg, G., Jr. (1993). Trichloroethylene exposure in vapour degreasing and the urinary excretion of N-acetyl-β-D-glucosaminidase. Arch. Toxicol. 67, 224-226.
103. Smith, A. E., Gray, G. M., and Evans, J. S. (1995). The ability of predicted internal dose measures to reconcile tumor bioassay data for chloroform. Regul. Toxicol. Pharmacol. 21, 339-351.
104. Spirtas, R., Stewart, P. A., Lee, J. S., Marano, D. E., Forbes, C. D., Grauman, D. J., Pettigrew, H. M., Blair, A., Hoover, R. N., and Cohen, J. L. (1991). Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. Br. J. Ind. Med. 48, 515-530.
105. Steinberg, A. D. (1993). Should chloral hydrate be banned? Pediatrics 92, 442-446.
106. Steinberg, A. D., and DeSesso, J. M. (1993). Have animal data been used inappropriately to estimate risks to humans from environmental trichloroethylene? Regul. Toxicol. Pharmacol. 18, 137-153.
107. 1 cells. J. Biol. Chem. 261, 3325-3332.
108. Stewart, P. A., Lee, J. S., Marano, D. E., Spirtas, R., Forbes, C. D., and Blair, A. (1991). Retrospective cohort mortality study of workers at an aircraft maintenance facility. II. Exposures and their assessment. Br. J. Ind. Med. 48, 515-530.
109. Templin, M. V., Parker, J. C., and Bull, R. J. (1993). Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol. Appl. Pharmacol. 123, 1-8.
110. United States. (1996). Code of Federal Regulations, Title 40, Part 141, Subpart G (National Revised Primary Drinking Water Regulations: Maximum Contaminant Levels), Section 141.61 (as amended July 1, 1994).
111. U.S. Environmental Protection Agency (EPA) (1985). Health Assessment Document for Trichloroethylene (EPA/600/8-82/006F). U.S. EPA Office of Research and Development, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Research Triangle Park, NC 27711.
112. U.S. Environmental Protection Agency (EPA) (1987). Addendum to the Health Assessment Document for Trichloroethylene: Updated Carcinogenicity Assessment for Trichloroethylene (EPA/600/8-82/ 006F: A review draft). U.S. EPA Office of Research and Development, Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Research Triangle Park, NC 27711.
113. 2μ-globulin: Association with Chemically Induced Renal Toxicity and Neoplasia in the Male Rat (EPA/625/3-91/019F). U.S. EPA Risk Assessment Forum, Washington, DC.
114. U.S. Environmental Protection Agency (EPA) (1996). Proposed guidelines for carcinogen risk assessment. Fed. Reg. 61 (Apr 23), 17960-18011.
115. U.S. Occupational Safety and Health Administration (OSHA) (1993). Department of Labor, OSHA FELs: Final rule (amending 20 CFR 1910). Fed. Reg. 58 (Mar 27), 35338-35351.
116. 1 cells - A comparative investigation with growth factors and 12-O-tetradecanoylphorbolacetate. Cell Biol. Toxicol. 9, 1-13.
117. Vamvakas, S., Elfarra, A. A., Dekant, W., Henschler, D., and Anders, M. W. (1988). Mutagenicity of amino acid and glutathione S-conjugates in the Ames test. Mutat. Res. 206, 83-90.
118. 35S-1,2-dichloroovinyl-L-cysteine nephrotoxicity in vivo and in cultured proximal tubule epithelial cells. Lab. Invest. 66.
119. Weiss, N. S. (1996). Cancer in relation to occupational exposure to trichloroethylene. Occup. Environ. Med. 53, 1-5.
120. Wiegand, R. G., Buddenhage, J. D., and Endicott, C. J. (1963). Multiple dose excretion kinetics. J. Pharm. Sci. 52, 268-273.
121. Wolfram, S. (1991). Mathematica: A System for Doing Mathematics by Computer. Addison-Wesley, Redwood City, CA.